Trade Basilea Pharma AG - BSLN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.20 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.011451% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.010771% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | CHF | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Switzerland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 42.1 |
| Open | 41.95 |
| 1-Year Change | 2.07% |
| Day's Range | 41.95 - 43.05 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 23, 2025 | 42.10 | 0.80 | 1.94% | 41.30 | 42.40 | 40.30 |
| Apr 22, 2025 | 40.60 | -0.45 | -1.10% | 41.05 | 41.05 | 39.45 |
| Apr 17, 2025 | 41.20 | 0.35 | 0.86% | 40.85 | 41.65 | 40.25 |
| Apr 16, 2025 | 41.45 | 0.85 | 2.09% | 40.60 | 41.60 | 40.35 |
| Apr 15, 2025 | 41.35 | 1.25 | 3.12% | 40.10 | 41.40 | 39.80 |
| Apr 14, 2025 | 40.20 | 0.20 | 0.50% | 40.00 | 40.95 | 38.90 |
| Apr 11, 2025 | 39.35 | -1.05 | -2.60% | 40.40 | 40.40 | 38.40 |
| Apr 10, 2025 | 39.55 | -2.30 | -5.50% | 41.85 | 41.85 | 38.70 |
| Apr 9, 2025 | 39.30 | 0.85 | 2.21% | 38.45 | 39.65 | 37.85 |
| Apr 8, 2025 | 40.80 | 0.70 | 1.75% | 40.10 | 41.40 | 39.40 |
| Apr 7, 2025 | 38.85 | 1.50 | 4.02% | 37.35 | 40.80 | 36.65 |
| Apr 4, 2025 | 40.05 | -1.60 | -3.84% | 41.65 | 41.95 | 38.85 |
| Apr 3, 2025 | 42.40 | -0.75 | -1.74% | 43.15 | 43.15 | 41.70 |
| Apr 2, 2025 | 43.25 | -1.00 | -2.26% | 44.25 | 44.25 | 41.95 |
| Apr 1, 2025 | 44.75 | -0.55 | -1.21% | 45.30 | 45.50 | 43.80 |
| Mar 31, 2025 | 45.10 | -0.65 | -1.42% | 45.75 | 46.00 | 44.10 |
| Mar 28, 2025 | 46.40 | 0.00 | 0.00% | 46.40 | 46.75 | 45.50 |
| Mar 27, 2025 | 46.65 | 0.55 | 1.19% | 46.10 | 46.95 | 45.65 |
| Mar 26, 2025 | 46.70 | 0.05 | 0.11% | 46.65 | 46.75 | 45.40 |
| Mar 25, 2025 | 46.90 | -0.15 | -0.32% | 47.05 | 47.30 | 46.00 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Basilea Company profile
About Basilea Pharmaceutica AG
Basilea Pharmaceutica AG is a Switzerland-based commercial-stage biopharmaceutical company. The Company operates in one segment, which is the discovery, development and commercialization of innovative pharmaceutical products to meet the needs of patients with cancer and infectious diseases. It launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. Additionally It is conducting clinical studies with two targeted drug candidates for the treatment of a range of cancers and have a number of preclinical assets in both cancer and infectious diseases in its portfolio.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Basilea Pharmaceutica AG revenues increased 16% to SF148.1M. Net loss decreased 54% to SF6.8M. Revenues reflect Japan segment increase of 41% to SF56.5M, Republic of Ireland segment increase of 9% to SF62.1M. Lower net loss reflects Research & development expenses, net - B decrease of 4% to SF91.6M (expense), Stock-based Compensation in SGA decrease of 6% to SF1.7M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
Hegenheimermattweg 167b
ALLSCHWIL
BASEL-LANDSCHAFT 4123
CH
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com